SOPHiA GENETICS Announces L’hôpital Universitaire Avicenne is Live on SOPHiA DDM™
The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE,...
Patient Care
AvaSure to Acquire Ouva’s AI-Powered Smart Room Solutions
Acquisition will expand ambient AI capabilities of AvaSure's Intelligent Virtual Care Platform, driving improvements in patient care and operational efficiency...
HRX 2024 IGNITES INNOVATION FOR CUTTING-EDGE BREAKTHROUGHS IN CARDIOVASCULAR MEDICINE AND DIGITAL HEALTH
Thought leaders, trailblazers, and advocates gather to explore the forefront of discoveries and advance partnerships between medicine and technology. ATLANTA,...
Techsomed Announces U.S. Launch of BioTraceIO Vision and BioTraceIO Precision Software for Image-Guided Ablation Therapy
REHOVOT, Israel, July 29, 2024 /PRNewswire/ -- Techsomed Ltd., a pioneering medical software company, announced today the U.S. launch of...
Interpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic Cysts
PARSIPPANY, NJ, July 29, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, (“Interpace” or the “Company”) (OTCQX:...
iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography
Windsong Radiology to Champion First Wave of ProFound AI Breast Health Suite ExpansionNASHUA, N.H. and WILLIAMSVILLE, N.Y. and RALEIGH, N.C.,...
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
-- Achieved primary endpoint of LS mean reduction in LDL-C on top of maximally tolerated lipid modifying therapies at day...
AliveDx Receives IVDR CE Mark for Groundbreaking Microarray Immunoassay in Allergy Diagnostics
EYSINS, Switzerland, July 29, 2024 /PRNewswire/ -- AliveDx ("Company") is proud to announce it has received IVDR CE mark for...
NewAmsterdam Pharma to Announce Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia on Monday, July 29, 2024
Company to host conference call on Monday, July 29 at 8:30 a.m. ETNAARDEN, the Netherlands and MIAMI, July 26, 2024...
BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo
July 26, 2024 News Release BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo ADLM...
Business Intelligence In The Healthcare Sector Market size is set to grow by USD 14.20 billion from 2024-2028, Improved efficiency of bi tools to boost the market growth, Technavio
NEW YORK, July 26, 2024 /PRNewswire/ -- The global business intelligence in the healthcare sector market size is estimated to grow...
Specialty Enzymes Market to Surpass USD 10.4 Billion by 2034, Growing at a 6.4% CAGR: Digital Technologies and Automation Drive Efficiency and Cost Reduction | TMR
Growing consumer awareness of enzyme benefits fuels demand for enzyme-based products in various health and wellness sectors. WILMINGTON, Del., July...
OmniGuide Holdings Announces Successful Completion of Patient Study for Revolutionary iSTONE(TM) Laser-Guided Lithotripsy Technology
BILLERICA, MA / ACCESSWIRE / July 26, 2024 / OmniGuide Holdings, Inc. (OGH) is thrilled to announce the successful completion...
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
Southlake, TX, July 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the...
Johnson & Johnson Receives Positive CHMP Opinion for Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
If approved, Yuvanci® would become the only single tablet combination for treatment for patients with PAH Johnson & Johnson’s comprehensive...
OnKure Announces the Appointment of Dylan Hartley as Chief Scientific Officer
BOULDER, Colo., July 25, 2024 (GLOBE NEWSWIRE) -- OnKure, Inc. today announced that Dylan Hartley, Ph.D. has been appointed to...
Medicom Secures Strategic Expansion Capital from UPMC Enterprises, TGH Ventures, Cone Health Ventures, Customers Bank, and More
RALEIGH, N.C., July 25, 2024 /PRNewswire/ -- Medicom, a health tech startup leading enterprise imaging interoperability, today announced completion of its...
Renew Biotechnologies Welcomes Steven Abbott as Chief Operating Officer to Lead Wasatch BioLabs’ Transition to Commercial Operations
HEBER CITY, Utah, July 25, 2024 /PRNewswire/ -- Renew Biotechnologies, a leading biotech company dedicated to pioneering NGS-based diagnostic solutions, appoints...
AbbaDox and Merge Partner to Enhance Radiology Workflow Solutions
MIAMI, July 25, 2024 /PRNewswire/ -- AbbaDox, a leading provider of cloud-based healthcare solutions, is pleased to announce a strategic...
QuVa Pharma Completes Acquisition of LogicStream Health Combination Creates Integrated Platform of Compounded Medications, Distribution Services, and AI-Powered Data Solutions
Uniquely empowers customers to proactively combat drug shortages and rising pharmacy costs through predictive analytics and insights that support inventory...